Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Polaprezinc/Zinc L-carnosine (Hepilor) in Infants With Gastroesophageal Reflux

NCT06678997 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT06678997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06678997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Polaprezinc/Zinc L-carnosine (Hepilor) in Infants With Gastroesophageal Reflux
Lead sponsor
University of Roma La Sapienza
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2024
Completion date
July 1, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux (ger), infants